Internal antigen and immune network.

Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect Immun (1988) 0.93

Idiotypic self binding of a dominant germline idiotype (T15). Autobody activity is affected by antibody valency. J Exp Med (1987) 0.88

Immunoglobulin with complementary paratope and idiotope. J Exp Med (1986) 0.86

Isolation of alpaca anti-idiotypic heavy-chain single-domain antibody for the aflatoxin immunoassay. Anal Chem (2013) 0.84

Biological mimicry of antigenic stimulation: analysis of the in vivo antibody responses induced by monoclonal anti-idiotypic antibodies. Immunology (1988) 0.80

Antiidiotypic antibody vaccine in murine Schistosomiasis mansoni comprising the internal image of antigen. J Clin Invest (1989) 0.78

XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol (1998) 4.51

Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol (1989) 4.07

Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81

PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem (1999) 2.92

Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J (1999) 2.75

High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol (1997) 2.59

Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med (1979) 2.53

The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43

Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23

Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity. J Immunol (1975) 2.15

Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science (1993) 1.96

Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol (1992) 1.88

Evaluation of surgical gamma probes for radioguided sentinel node localisation. Eur J Nucl Med (1998) 1.82

Cellular basis of regulation of expression of idiotype. II. Immunity to anti-MOPC-460 idiotype antibodies increases the level of anti-trinitrophenyl antibodies bearing 460 idiotypes. J Exp Med (1979) 1.76

Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods (1985) 1.76

Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet (1999) 1.76

Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J Virol (1993) 1.70

Identification by immunoprecipitation of cauliflower mosaic virus in vitro major translation product with a specific serum against viroplasm protein. EMBO J (1982) 1.69

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses (1993) 1.67

In vivo competition between self peptides and foreign antigens in T-cell activation. Nature (1988) 1.66

Sequence requirements for plasmid nuclear import. Exp Cell Res (1999) 1.63

Blastic transformtion of mouse spleen lymphocytes by a water-soluble mitogen extracted from Nocardia. Proc Natl Acad Sci U S A (1974) 1.62

Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science (1984) 1.59

Detection of papillomavirus DNA in human semen. Science (1986) 1.59

Immune response to levan. I. Kinetics and ontogeny of anti-levan and anti-inulin antibody response and of expression of cross-reactive idiotype. J Immunol (1978) 1.57

Proteases as mitogens. The Effect of trypsin and pronase on mouse and human lymphocytes. Exp Cell Res (1974) 1.56

Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect Immun (1975) 1.54

Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice. Mol Immunol (1993) 1.51

A rapid screening procedure to identify mini-Tn10 insertion mutants of Escherichia coli K-12 with altered adhesion properties. FEMS Microbiol Lett (1996) 1.49

Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis (1996) 1.46

The effect of poly(ADP-ribosyl)ation on native and H1-depleted chromatin. A role of poly(ADP-ribosyl)ation on core nucleosome structure. J Biol Chem (1989) 1.46

Identification of a new V kappa gene family that is highly expressed in hybridomas from an autoimmune mouse strain. J Immunol (1990) 1.46

Conditions that induce tolerance in mature CD4+ T cells. J Exp Med (1997) 1.45

Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg (2001) 1.45

Trials in primary care: statistical issues in the design, conduct and evaluation of complex interventions. Stat Methods Med Res (2010) 1.42

Use of self-retaining barbed suture for rectal wall closure in transanal endoscopic microsurgery. Tech Coloproctol (2014) 1.40

Mitogenic effect of a water-soluble extract of Nocardia opaca: a comparative study with some bacterial adjuvants on spleen and peripheral lymphocytes of four mammalian species. J Immunol (1974) 1.40

Target cells for the activity of a synthetic adjuvant: muramyl dipeptide. Cell Immunol (1977) 1.36

Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny. J Immunol (1979) 1.34

A human T-independent B lymphocyte mitogen extracted from Nocardia opaca. J Immunol (1976) 1.33

Detection of poly(ADP ribose) polymerase in crude extracts by activity-blot. Anal Biochem (1991) 1.30

The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys (1997) 1.26

Amino acid sequence of the N alpha-terminal 201 residues of human erythrocyte membrane band 3. J Biol Chem (1983) 1.26

Blast transformation of rabbit B-derived lymphocytes by a mitogen extracted from Nocardia. J Immunol (1975) 1.25

E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ (2009) 1.24

Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. J Exp Med (1981) 1.24

[Serological evolution of infection by Plasmodium malariae: variations of fluorescent antibody titre after radical treatment]. Bull World Health Organ (1969) 1.22

Expression and site-directed mutagenesis of the catalytic domain of human poly(ADP-ribose)polymerase in Escherichia coli. Lysine 893 is critical for activity. J Biol Chem (1990) 1.22

Polyclonal activation of human B lymphocytes by Nocardia water soluble mitogen (NWSM). Immunol Rev (1979) 1.19

Murine V kappa gene expression does not follow the VH paradigm. J Exp Med (1989) 1.19

Cell suppression in PPD-induced blast specific response of human peripheral blood lymphocytes. Clin Exp Immunol (1976) 1.18

Presence and subcellular localization of two distinct mitogenic fractions in the cells of Nocardia rubra and Nocardia opaca: preparation of soluble mitogenic peptidoglycan fractions. Infect Immun (1976) 1.18

Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol (1999) 1.18

Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Proc Natl Acad Sci U S A (1994) 1.17

The fluorescent antibody technique in the estimation of immunity in patients infected with Plasmodium malariae. Trans R Soc Trop Med Hyg (1966) 1.17

[The value of the immunofluorescent reaction in the detection of asymptomatic parasitemia due to Plasmodium malariae]. Bull World Health Organ (1967) 1.17

Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunol Today (1999) 1.17

Immunity under the skin: potential application for topical delivery of vaccines. Vaccine (2003) 1.16

Regulation of the anti-inulin antibody response by a nonallotype-linked gene. J Exp Med (1980) 1.14

Mitogenic analysis of murine B-cell heterogeneity. J Exp Med (1978) 1.13

Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes. J Invest Dermatol (2001) 1.13

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study. Eur J Cancer (2000) 1.12

Gastric adenocarcinoma associated with adenomyoma of the stomach. Postgrad Med J (1988) 1.12

D-peptides as immunogens and diagnostic reagents. Curr Opin Biotechnol (1998) 1.11

Genetic and cellular regulation of the expression of specific antibody idiotypes in the anti-polyfructosan immune response. Ann Immunol (Paris) (1979) 1.10

Antibodies from patients with rheumatoid arthritis and juvenile chronic arthritis analyzed with core histone synthetic peptides. Int Arch Allergy Appl Immunol (1990) 1.09

Transfer of antigenic macromolecules from macrophages to lymphocytes. I. Autoradiographic and quantitative study of ( 14 C)endotoxin and ( 125 I)haemocyanin transfer. Immunology (1972) 1.09

Comparison of different methods for localizing antigenic regions in histone H2A. Mol Immunol (1986) 1.09

Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg (2000) 1.08

The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J Biol Chem (1999) 1.08

Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells. J Biol Chem (1998) 1.08

Anti-immunoglobulin antibodies. I. Expression of cross-reactive idiotypes and Ir gene control of the response to IgG2a of the b allotype. J Exp Med (1980) 1.08

Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera. Clin Exp Immunol (1991) 1.08

IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein. Clin Exp Immunol (1992) 1.07

Working life of health professionals. World Health Stat Q (1979) 1.06

Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care (1995) 1.06

Regulation of thymocyte development through CD3: functional dissociation between p56lck and CD3 sigma in early thymic selection. Immunity (1995) 1.05

Unconscious mood-congruent memory bias in depression. J Abnorm Psychol (1996) 1.05

Dichloromethane utilized by an anaerobic mixed culture: acetogenesis and methanogenesis. Biodegradation (1991) 1.04

Idiotypic determinants of rabbit B- and T-derived lymphocytes. Immunol Rev (1977) 1.04

Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol (2000) 1.04

Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells. J Immunol (1998) 1.03

An ELISA for detection of apoptosis. Nucleic Acids Res (1997) 1.03

Ultrasound guided cytological aspiration of supraclavicular lymph nodes in patients with suspected lung cancer. Thorax (2005) 1.03

The carboxyl-terminal domain of human poly(ADP-ribose) polymerase. Overproduction in Escherichia coli, large scale purification, and characterization. J Biol Chem (1993) 1.03

A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies. J Exp Med (1989) 1.02

Recognition of synthetic peptides of Sm-D autoantigen by lupus sera. Clin Exp Immunol (1990) 1.02

Immune response to levan. II. T independence of suppression of cross-reactive idiotypes by anti-idiotype antibodies. J Immunol (1979) 1.02

An immunohistochemical and clinicopathological study of granulocytic sarcoma ('chloroma'). Hematol Oncol (1986) 1.02

Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein. Vaccine (1998) 1.01

Prospective randomized study of monopolar scissors, bipolar vessel sealer and ultrasonic shears in laparoscopic colorectal surgery. Br J Surg (2008) 1.01

Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J Biol Chem (2000) 1.00

DNA-bound transcription factor complexes analysed by mass-spectrometry: binding of novel proteins to the human c-fos SRE and related sequences. Nucleic Acids Res (2001) 1.00

Total chemical synthesis of ubiquitin using BOP reagent: biochemical and immunochemical properties of the purified synthetic product. Pept Res (1992) 1.00

Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge. Immunology (2001) 1.00

Towards a unified theory of immunoglobulin structure-function relations. Immunol Rev (1986) 1.00

Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol (2000) 1.00

Immunochemical detection of changes in chromatin subunits induced by histone H4 acetylation. EMBO J (1982) 0.99

Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. J Rheumatol (2001) 0.99

Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. J Immunol Methods (1992) 0.99